Our Story
Genabio Diagnostics Inc. is a global leader in at-home self-testing products, offering an extensive portfolio that includes infectious disease tests, women's health self-tests, men's infertility rapid tests, drug abuse rapid tests, and metabolic health monitoring products.
Genabio's products are highly acclaimed in global markets, with distribution channels across the U.S. states, the United Kingdom, Canada, India, and Japan. The company has secured substantial procurement contracts from governmental bodies in New York, Colorado, Connecticut, Georgia, and Los Angeles. Genabio supplies renowned institutions such as Boston University Hospital, New York University Hospital, and the University of Kansas Hospital. Our offerings are available in over 70,000 pharmacies and supermarkets, including prominent retailers like Walgreens, H-E-B, Walmart, Wegmans, Anda, UNFI, CVS, Associated Pharmacies, C&S Wholesale Grocers, Giant Eagle, and Top Rx. Additionally, Genabio has received significant orders from international diagnostic laboratories such as Eurofins Labs and Quest Diagnostics. Notably, our COVID-19 testing products rank second in sales among similar products on Amazon nationwide. We are also a trusted supplier to major healthcare product manufacturers and distributors such as Medline and Concordance Healthcare.
Since its inception, Genabio has achieved sales revenue exceeding $100 million and is currently in a phase of rapid development. We have invested in ARCpoint Labs in the United States, which operates over 150 branches nationwide. Genabio is advancing through initial public offerings (IPOs) and mergers and acquisitions (M&A) of high-quality technology companies overseas. Our goal is to become the world's foremost provider of self-testing solutions, delivering precise, user-friendly, and cost-effective health diagnostics for individuals worldwide within the next 5-10 years.
At Genabio Diagnostics Inc., our success in the in vitro diagnostic market is driven by advanced technology, market expertise, and a robust collaborative network. Moving forward, we remain committed to innovation and excellence, aiming to lead the global in vitro diagnostics sector.
Our mission is to promote global health awareness and accessibility through cost-efficient, high-quality self-test products. We strive to pioneer innovation, broaden our impact, and empower individuals worldwide to monitor their health conveniently and accurately.
Genabio's products are highly acclaimed in global markets, with distribution channels across the U.S. states, the United Kingdom, Canada, India, and Japan. The company has secured substantial procurement contracts from governmental bodies in New York, Colorado, Connecticut, Georgia, and Los Angeles. Genabio supplies renowned institutions such as Boston University Hospital, New York University Hospital, and the University of Kansas Hospital. Our offerings are available in over 70,000 pharmacies and supermarkets, including prominent retailers like Walgreens, H-E-B, Walmart, Wegmans, Anda, UNFI, CVS, Associated Pharmacies, C&S Wholesale Grocers, Giant Eagle, and Top Rx. Additionally, Genabio has received significant orders from international diagnostic laboratories such as Eurofins Labs and Quest Diagnostics. Notably, our COVID-19 testing products rank second in sales among similar products on Amazon nationwide. We are also a trusted supplier to major healthcare product manufacturers and distributors such as Medline and Concordance Healthcare.
Since its inception, Genabio has achieved sales revenue exceeding $100 million and is currently in a phase of rapid development. We have invested in ARCpoint Labs in the United States, which operates over 150 branches nationwide. Genabio is advancing through initial public offerings (IPOs) and mergers and acquisitions (M&A) of high-quality technology companies overseas. Our goal is to become the world's foremost provider of self-testing solutions, delivering precise, user-friendly, and cost-effective health diagnostics for individuals worldwide within the next 5-10 years.
At Genabio Diagnostics Inc., our success in the in vitro diagnostic market is driven by advanced technology, market expertise, and a robust collaborative network. Moving forward, we remain committed to innovation and excellence, aiming to lead the global in vitro diagnostics sector.
Our mission is to promote global health awareness and accessibility through cost-efficient, high-quality self-test products. We strive to pioneer innovation, broaden our impact, and empower individuals worldwide to monitor their health conveniently and accurately.
Our Sites
We focus on connecting missing links, reacting fast to bring the most needed products and services to the labs around the world.
Global Clients
Subscription
We can help you figure out your needs.